CVS Health Return on Tangible Equity 2010-2025 | CVS

Current and historical return on tangible equity values for CVS Health (CVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CVS Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $5.28B $-40.66B -12.28%
2024-12-31 $4.61B $-42.87B -10.41%
2024-09-30 $5.02B $-43.98B -11.26%
2024-06-30 $7.19B $-44.47B -15.92%
2024-03-31 $7.32B $-45.89B -15.87%
2023-12-31 $8.34B $-43.87B -18.81%
2023-09-30 $8.63B $-46.38B -20.95%
2023-06-30 $2.97B $-48.38B -7.87%
2023-03-31 $4.09B $-38.85B -12.27%
2022-12-31 $4.31B $-31.18B -13.46%
2022-09-30 $3.37B $-32.23B -10.41%
2022-06-30 $8.38B $-31.19B -25.49%
2022-03-31 $8.13B $-33.46B -23.86%
2021-12-31 $8.00B $-32.77B -22.55%
2021-09-30 $7.58B $-34.05B -20.19%
2021-06-30 $7.20B $-36.07B -18.21%
2021-03-31 $7.40B $-39.03B -17.81%
2020-12-31 $7.18B $-40.99B -16.47%
2020-09-30 $7.95B $-42.16B -17.48%
2020-06-30 $8.26B $-43.93B -17.37%
2020-03-31 $7.22B $-47.25B -14.57%
2019-12-31 $6.63B $-48.70B -12.93%
2019-09-30 $4.47B $-50.27B -8.38%
2019-06-30 $4.33B $-52.05B -9.97%
2019-03-31 $-0.17B $-54.22B 0.51%
2018-12-31 $-0.59B $-56.66B 2.58%
2018-09-30 $3.11B $-10.76B -24.94%
2018-06-30 $3.01B $-11.93B -21.58%
2018-03-31 $6.67B $-12.83B -43.62%
2017-12-31 $6.62B $-14.39B -40.05%
2017-09-30 $5.04B $-16.60B -30.25%
2017-06-30 $5.30B $-17.34B -32.15%
2017-03-31 $5.12B $-17.81B -31.22%
2016-12-31 $5.32B $-14.93B -33.41%
2016-09-30 $5.11B $-15.83B -32.17%
2016-06-30 $4.81B $-17.06B -31.50%
2016-03-31 $5.16B $-15.83B -46.14%
2015-12-31 $5.24B $-14.78B -70.30%
2015-09-30 $5.06B $-13.46B -135.19%
2015-06-30 $4.76B $-0.67B -1352.84%
2015-03-31 $4.74B $-0.89B -2978.62%
2014-12-31 $4.64B $0.05B 5495.86%
2014-09-30 $4.59B $0.10B 850.42%
2014-06-30 $4.89B $0.10B 439.36%
2014-03-31 $4.77B $0.09B 270.62%
2013-12-31 $4.59B $1.87B 207.43%
2013-09-30 $4.44B $2.40B 209.25%
2013-06-30 $4.20B $2.70B 247.46%
2013-03-31 $4.04B $1.90B 284.10%
2012-12-31 $3.86B $1.51B 275.12%
2012-09-30 $3.81B $0.69B 261.30%
2012-06-30 $3.68B $1.60B 237.94%
2012-03-31 $3.53B $1.82B 230.92%
2011-12-31 $3.46B $1.72B 202.34%
2011-09-30 $3.42B $1.03B 185.86%
2011-06-30 $3.36B $1.53B 181.32%
2011-03-31 $3.37B $2.56B 219.23%
2010-12-31 $3.43B $2.25B 384.09%
2010-09-30 $3.45B $1.09B 1076.23%
2010-06-30 $3.66B $0.25B 34083.72%
2010-03-31 $3.73B $-0.02B 9150.92%
2009-12-31 $3.70B $-0.04B -3820.16%
Sector Industry Market Cap Revenue
Medical Medical Services $80.430B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.286B 26.31
Elevance Health (ELV) United States $88.874B 11.47
Cencora (COR) United States $56.003B 19.48
DiDi Global (DIDIY) China $23.532B 35.71
Natera (NTRA) United States $22.361B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.999B 0.00
Solventum (SOLV) United States $12.948B 13.71
CochLear (CHEOY) Australia $11.388B 0.00
ICON (ICLR) Ireland $11.234B 10.44
Doximity (DOCS) United States $11.054B 51.17
Revvity (RVTY) United States $10.840B 18.66
Viatris (VTRS) United States $10.223B 3.51
HealthEquity (HQY) United States $9.646B 42.25
Avantor (AVTR) United States $8.906B 12.94
Medpace Holdings (MEDP) United States $8.522B 22.63
Sonic Healthcare (SKHHY) Australia $8.301B 0.00
Charles River Laboratories (CRL) United States $7.107B 13.93
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
BrightSpring Health Services (BTSG) United States $4.201B 38.89
Bausch + Lomb (BLCO) Canada $4.139B 24.38
Sotera Health (SHC) United States $3.491B 19.84
Alignment Healthcare (ALHC) United States $3.011B 0.00
Surgery Partners (SGRY) United States $2.972B 38.65
Concentras Parent (CON) United States $2.824B 16.32
Organon (OGN) United States $2.485B 2.64
Ardent Health Partners (ARDT) United States $2.126B 9.06
GeneDx Holdings (WGS) United States $2.056B 79.20
Premier (PINC) United States $1.889B 14.33
Progyny (PGNY) United States $1.858B 40.91
PACS (PACS) United States $1.591B 0.00
GoodRx Holdings (GDRX) United States $1.457B 29.14
Teladoc Health (TDOC) United States $1.275B 0.00
Pediatrix Medical (MD) United States $1.210B 9.21
Establishment Labs Holdings (ESTA) $1.099B 0.00
CareDx (CDNA) United States $1.087B 16.97
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.894B 0.00
AMN Healthcare Services Inc (AMN) United States $0.808B 7.56
QDM (QDMI) Hong Kong, SAR China $0.755B 0.00
Nutex Health (NUTX) United States $0.678B 10.26
LifeMD (LFMD) United States $0.578B 0.00
Embecta (EMBC) United States $0.572B 3.85
Enhabit (EHAB) United States $0.547B 45.00
InnovAge Holding (INNV) United States $0.543B 0.00
SBC Medicals (SBC) United States $0.489B 0.00
Auna S.A (AUNA) Luxembourg $0.482B 10.85
Sonida Senior Living (SNDA) United States $0.478B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.449B 0.00
Oncology Institute (TOI) United States $0.248B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.096B 0.00
So-Young (SY) China $0.092B 0.00
Pheton Holdings (PTHL) China $0.089B 0.00
OncoCyte (OCX) United States $0.085B 0.00
Basel Medical Group (BMGL) Singapore $0.073B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
Sera Prognostics (SERA) United States $0.058B 0.00
ModivCare (MODV) United States $0.057B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00